Unlock precision oncology insights with ddPCR technology
1 Dec 2025
Discover how Droplet Digital™ PCR is advancing precision monitoring in oncology through Development of a Highly Sensitive and Specific Droplet Digital PCR Assay for Multiplexed Detection and Longitudinal Monitoring of ESR1 Variants in Plasma: A QX600 Case Study, presented by Leisa Jackson, Scientist at Biodesix, and recorded earlier this year at ddPCR™ World.
The following presentation is part of a Bio-Rad hosted event for Droplet Digital PCR (ddPCR) research applications. The products are intended for research use only and are not intended for use in diagnostic procedures. Any clinical applications, test validations, or performance claims discussed are the sole responsibility of the presenting institution or speaker and do not reflect the views or endorsements of Bio-Rad Laboratories.
About the company
Bio-Rad
Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research products, clinical diagnostics, and analytical instrumentation, based in Hercules, California. The company serves more than 70,000 research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices.
Related products
Request Quote for All Products
QX600 Droplet Digital PCR System
Bio-RadThe QX600 Droplet Digital PCR System (ddPCR™) offers advanced six-color multiplexing and absolute quantification of nucleic acid while delivering the best-in-class performance you have come to expect from Bio-Rad’s ddPCR systems.
